Australia markets open in 8 hours 29 minutes

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8000+0.0570 (+7.67%)
At close: 04:00PM EDT
0.7732 -0.03 (-3.35%)
After hours: 06:42PM EDT

NeuroOne Medical Technologies Corporation

7599 Anagram Drive
Eden Prairie, MN 55344
United States
952 426 1383
https://www.n1mtc.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees16

Key executives

NameTitlePayExercisedYear born
Mr. David A. Rosa M.D.President, CEO & Director759.98kN/A1964
Mr. Ronald W. McClurgChief Financial Officer358.79kN/A1960
Mr. Steven MertensChief Technology Officer332.26kN/A1963
Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison260.85kN/A1967
Mr. Christopher R. Volker CFAChief Operating OfficerN/AN/AN/A
Mr. Hijaz HarisVice President of MarketingN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Corporate governance

NeuroOne Medical Technologies Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.